MedTrace Logo

Innovative Automated Insulin Delivery System for Type 2 Diabetes

NCT06853990 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-01-05

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes.

Conditions

Interventions

DEVICE

twiist insulin delivery system

twiist system includes a novel insulin pump, a CGM sensor and the DEKA Loop algorithm

Sponsors & Collaborators

  • Sequel Med Tech

    collaborator UNKNOWN

  • Deka Research and Development

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-14
Primary Completion
2026-04-30
Completion
2026-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06853990 on ClinicalTrials.gov